{"name":"Halia Therapeutics, Inc.","slug":"halia-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"HT-4253","genericName":"HT-4253","slug":"ht-4253","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"HT-4253","genericName":"HT-4253","slug":"ht-4253","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNa3JseTloMjM2RFJDcWwtZUlPaGo4Y000Z2dSZFhTTEpYeEowNjN0aV94UHNma3c1eW5FREtLM1l1RkZCcWlkMTV1RXVIOENYdmlIcGQ5YnY0VGZiZjdSSXNuZWVYdHpsOS1NbGVVMFpPYlBKbVFtaTNZNUlSRnNUcGsycFJ2V19qbS1RZFR0enM5ZGE3QzN1VFhqU0pPdGJiQkNxZ2JwWllseFRyWG1HRGhzZEs5Zk14eXo2RVNUMUxocUV1enhRRkJNb0J0NU1YcUptQ3BZLVRxVVhJbmpPSHFqbUJJSTZLNkhmYVhybnhoM0lCNld0UzhnLXRRdGlJNHBpcmd2RHpBS2FBYTVuTnZ1dTBmTUZXVU5XOTcwUGlMU3VBcFZYU3V0SFVSQ25MVkptNkQ1LVQ?oc=5","date":"2025-11-10","type":"regulatory","source":"prnewswire.com","summary":"Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting - prnewswire.com","headline":"Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American So","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQMFlTZW9LaUExR0NrTzlMU1NKbTRsZUU1MDJEYVJ3Y2tJOVMtWDgtdzN3WTBJNHhjRXRLSFFiYURUY2hKWEwwRjdQQmExV1lSQkxHNXA4RGdTV2JMdGVzVDBERHZyU2pRSW9tdWpTMUdFLVJmal9NRnVuLVFOVThCekNOZmtIX29Yc1h5bzRjdmlkUVBIdHB3TGwyeHprSW0tamJodFloU2ZhT1ZhbUFv?oc=5","date":"2025-10-06","type":"pipeline","source":"Contract Pharma","summary":"Halia Therapeutics Appoints Paul Jones as Chief Strategy Officer - Contract Pharma","headline":"Halia Therapeutics Appoints Paul Jones as Chief Strategy Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOTTh0U2dhRnBhWHRnVzFMVmsyQkpGckpMdlRBOFJJNDQ4TGZiV3V3bGI3cjFMOXB0Zll6ZWJpbVVXc0VoamtZa005cDBha0RvbC1fX3lmY19XTEZXcGhmRWw1WjRta1hxTTBMTVA4Z3pEZU4tUDhpNjRMUnBYWDl6ajE3bzZ4OG5POXM5RTczeTJfaUgtMWtzazRpbzNabDgzaVRmUWpRWEs4WmduUF96VE13Z3c1N0cteFpBUWtZeXlEd2Q5?oc=5","date":"2025-01-06","type":"pipeline","source":"prnewswire.com","summary":"Halia Therapeutics Strengthens Leadership and Clinical Operations Team - prnewswire.com","headline":"Halia Therapeutics Strengthens Leadership and Clinical Operations Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOX0FoOWNzLXNDM0hteFdQUnluOExDZzZPWVNCSGZDSkNKdGE4RzhfalJxdjFyLVdibENlcWNneXdaeHdrU3hDTFJzZU0yemFDWkV2SGhoZVl3T0I3bmV4YUh5YnN3M29YRjhMZk52ZV80azJ0OXhGbnBZU0VfRzhHX25MdXo0Z05Gc0ZiUlRYbTdua3U4XzkwRGtPNFRiYkNja1BnUXdJRTMxY3FQ?oc=5","date":"2025-01-06","type":"pipeline","source":"Contract Pharma","summary":"Halia Therapeutics Updates Leadership & Clinical Operations Team - Contract Pharma","headline":"Halia Therapeutics Updates Leadership & Clinical Operations Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOajNVQzFKUGZtQlJSTG00OTZBQ2tZTTVEeUc5YU04T2NPRmx5TjB2OHFJNUhWOGozUVZNSVBxSGFDbU9fTkdzX0IycjhseHlnNWtKZUJDd09aZXluaEd5VFR6OHBoV2x3T3NreU00NVpEV1pMZkducXNzcWNPaFpsaW44VjJsQ2FVci1pTmdR?oc=5","date":"2024-11-13","type":"trial","source":"Yahoo Finance","summary":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight - Yahoo Finance","headline":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxQT2lzdlZvUURyZUdldVdUUUFQbG5JVXhhbEg2aG4yOUVlek9Ga3pwOWFGOFhNRHNQY1pfVVZKWUJGUFozeU1FRklGdFVBUllvUUdqeGo5dU0zTHhHeWZUeHRtSjVhYmttUFlraDBSTWxtcnMzWVhjbFFPSEVtVFN1aUtVOHExTkZrZHMtbGxCVzl3dTl6V0ExamtKUmFYbUd4T25NdzdXSDQzakloRVJLNmFNNjZWdERUbGNWT2RDUmUzOUFYalhOQWJlZUtKLXkzX0E2TFdKT2ZSdHV1RlFjMFpfQ1A4TDhicFJqbTN1aVNHY3ZrZi02N3FXZXpxU2JyVjBlMVEzeUEtMVhkOHBEZ2RGcjN2dTc1N2R6MTZGSzBvRjRIYzJNNXFhRjF5SWM?oc=5","date":"2024-10-07","type":"pipeline","source":"prnewswire.com","summary":"Halia Therapeutics Announces First Healthy Volunteer Dosed with HT-4253, a Novel Oral LRRK2 Inhibitor Targeting Neuroinflammation in Alzheimer's Disease - prnewswire.com","headline":"Halia Therapeutics Announces First Healthy Volunteer Dosed with HT-4253, a Novel Oral LRRK2 Inhibitor Targeting Neuroinf","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxOdlZXTGxZaHBoR0pKMV9rbWNpczlUMjd4TVIyUGVpLThJUDhMU2U0NDhTRGJhWHE3ZDcybXpmWE9ERW9yYzNYMjZBN0dQVzUyVzRmSGNyX2xNaDFkejFxYm1BcE5zdFhMREJnZ21waVlEamFxVWpOaE5NZDdURG9YcVFuVUZBbWx0Ri1DMHMycDRLLTRFVGtfMklXYlpjSzBMbG9lUlNhNWxyOGlRVmFmWS1DblFrSE1Xc1BMTXhLcFJhN21jSnhDaWh4SFBkaUZUMDZlbHNldzUwV1IxYjRKVXdWOTI2cXlXTTJGalpmZDF4Mm5CbmE3T0hYWGh1bjJGR0tyc3lyZlJrMmozMzFKQVhHN0hyeC0taGkybjE5aFpGYXZQTUZIQUZTT3d0N01JU3lrZ1l3R3dmY2g3ODV6UQ?oc=5","date":"2024-09-03","type":"pipeline","source":"prnewswire.com","summary":"Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases - prnewswire.com","headline":"Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxONzBxb0dvQXRRWEFWZUdpZzdMcFJwWFhpZ2U0bDhtbFI2cDBfMFlxVmJtZ1dLUS1pNm1NUXBrNUo4TnNOZHFxOWNETll4bjZfTjFYbTdEckw3eXgxTkMwVGFUQmNYLW1VUXdwYWhseHkyV0JiRGZBekRTN2tXbVVMM1M1NTYyaFNNeEt4d0F1QWxGbmlBN2VjQ1pxdVY4WmozZi1rLXlBVVdvU1hnUWQ3Ry1yNnZjVmptUHAzcTVDczlwWm5JVjRvOQ?oc=5","date":"2024-07-19","type":"pipeline","source":"24-7 Press Release Newswire","summary":"David J. Bearss, PhD Celebrated for Dedication to the Pharmaceutical Industry - 24-7 Press Release Newswire","headline":"David J. Bearss, PhD Celebrated for Dedication to the Pharmaceutical Industry - 24-7 Press Release Newswire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPOXRxMGFZZmpuQm5WbW42YXFvNThHd3hyR0l5Vm12Wkx3V1hidFBsbG0zdFd4dnF0cC1vNk9jZTY5YjFoZ0hoM2FsSmlrbldOUXpLSm9sc2pCUEdpM0QzX3NpeEkwR0pIemJsaWF1cEh3MHYtVXJaLUFZbW9XME5TSnc0dXlKaXo5ejhWLUZPdEF2RHNkam1ZbHhmckVRTkhjWHFjOEdrU0hHWVZ4LWRva3hVazBkSXhCbEZXTTFwZnV2VzFsa2RrczZxcHNlVFk0WjBwcDh1ZnpMVWNEV3diZW11S3VUVjBiWlRkRngxXzhKMm1IUk1TNUVUMA?oc=5","date":"2024-01-31","type":"pipeline","source":"prnewswire.com","summary":"Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics - prnewswire.com","headline":"Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}